Related Experiment Video
Updated: Jun 29, 2025
08:32
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
145
CRISPR and Gene Editing: A Game-changer in Drug Development
Abhishek Verma1, Tarun Sharma1, Ankit Awasthi1
1Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab 142001, India.
Current Pharmaceutical Design
|April 8, 2024
Summary
CRISPR gene editing offers precise medical treatments for genetic disorders and revolutionizes drug development. Responsible implementation requires addressing ethical concerns and ensuring equitable access to these transformative technologies.
Area of Science:
- Biotechnology
- Genetics
- Medical Science
Background:
- CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) gene editing is a revolutionary technology.
- It enables precise targeting of genetic disorders and impacts drug development.
- Its applications span hereditary diseases, infectious diseases, and cancer therapy.
Purpose of the Study:
- To review the broad impact of CRISPR gene editing in medicine.
- To highlight its potential in personalized medicine, therapeutic innovation, and pandemic prevention.
- To examine its role in reshaping drug development processes.
Main Methods:
- Literature review of CRISPR applications in various medical fields.
- Analysis of CRISPR's potential in personalized medicine and drug development.
- Discussion of ethical considerations and commercialization challenges.
Main Results:
- CRISPR demonstrates significant potential across diverse medical applications.
- It offers novel approaches for treating genetic disorders and developing new drugs.
- Ethical debates surrounding germline editing and access are critical.
Conclusions:
- CRISPR technology is transforming medicine with vast therapeutic potential.
- Navigating ethical, commercial, and equity issues is crucial for responsible advancement.
- Collaboration is essential to ensure CRISPR benefits future generations.
Related Concept Videos
01:59CRISPR
50.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.8K
02:53CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
00:49What is Genetic Engineering?
74.1K
Overview
74.1K
02:31Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K